Chagas' Disease: Clinical Trials

3 trials for Chagas' Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 1 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 41Completed 1

Follow Chagas' Disease: new trials by email Literature Review of Chagas' Disease trials Research Report on Chagas' Disease

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Assess the Food Effect on the Pharmacokinetics of Nifurtimox Tablets in Chronic Chagas' Patients - Dietary Habits Study
Nifurtimox (Lampit, BAYA2502) - Chagas' Disease
Phase 1CompletedBayer362019-06-102020-12-30
Study on Benefits of Therapy With Nifurtimox in Chagas Disease, a Parasitic Illness Mostly Transmitted to Humans by a Bug, Using Information From Patient Medical Records in Argentina
Lampit (Nifurtimox, BAYA2502) - Chagas' Disease
CompletedBayer30002018-12-142021-04-08
Population Pharmacokinetics Study of Benznidazole in Children With Chagas'Disease
Benznidazole 12,5mg or 100mg - Chagas' Disease
Phase 4CompletedDrugs for Neglected Diseases802011-05-012018-06-25

Narrower conditions

Chagas Disease (3)

Broader conditions

Euglenozoa Infections (3)  ·  Infections (3)  ·  Parasitic Diseases (3)  ·  Protozoan Infections (3)  ·  Trypanosomiasis (3)  ·  Vector Borne Diseases (3)

Interventions

Nifurtimox (2)

Sponsors

Bayer (2)  ·  Drugs for Neglected Diseases (1)

Countries

Argentina (3)

Top investigators

Jaime Altcheh, MD (1)

Results publications

PMID 34265407, PMID 34606501, PMID 37256863